Take Solutions Ltd

Take Solutions Ltd

₹ 22.0 -1.30%
14 Jun - close price
About

Incorporated in 2000, TAKE Solutions Ltd is in the business of Life Sciences and Support Services[1]

Key Points

Business Overview:[1]
Singapore-based TAKE Solutions Pte Limited holds a 52.90% stake in TSL, serving as the holding company. TSL specializes in Life Sciences and Supply Chain Management, providing comprehensive services in clinical development and specific offerings in supply chain. The company is involved in clinical trials, generics support, including bio-availability & bioequivalent studies, regulatory filing, and pharmacovigilance.

  • Market Cap 326 Cr.
  • Current Price 22.0
  • High / Low 35.8 / 16.2
  • Stock P/E
  • Book Value -0.60
  • Dividend Yield 0.00 %
  • ROCE -21.6 %
  • ROE -55.0 %
  • Face Value 1.00

Pros

  • Company has reduced debt.

Cons

  • Company has low interest coverage ratio.
  • The company has delivered a poor sales growth of -49.7% over past five years.
  • Company has a low return on equity of -106% over last 3 years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Miscellaneous Industry: Miscellaneous

Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024
221 209 197 207 41 57 43 51 38 17 18 17 13
179 178 174 225 69 60 70 55 27 19 16 16 28
Operating Profit 42 31 24 -18 -28 -3 -26 -4 11 -1 2 1 -15
OPM % 19% 15% 12% -8% -68% -5% -61% -8% 29% -7% 10% 7% -115%
-68 3 2 9 -690 -17 23 1 -59 -0 0 1 -93
Interest 8 11 8 9 2 2 1 1 4 2 1 1 1
Depreciation 28 25 26 23 5 5 4 4 4 2 2 2 2
Profit before tax -62 -3 -7 -41 -725 -27 -8 -8 -56 -5 -2 -1 -111
Tax % -10% -28% -22% -3% -0% 2% 0% -31% 0% -5% 4% -123% 0%
-68 -3 -9 -42 -725 -26 -8 -10 -56 -5 -2 -2 -111
EPS in Rs -4.60 -0.22 -0.60 -2.83 -48.99 -1.77 -0.54 -0.69 -3.78 -0.36 -0.10 -0.14 -7.48
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
832 816 730 1,030 1,345 1,587 2,039 2,213 774 655 189 66
670 668 581 817 1,082 1,281 1,655 2,044 847 648 208 79
Operating Profit 161 147 149 213 262 307 384 169 -73 7 -19 -13
OPM % 19% 18% 20% 21% 20% 19% 19% 8% -9% 1% -10% -21%
7 6 8 21 13 6 11 26 -211 -677 -56 -92
Interest 14 14 13 15 23 21 25 41 37 29 7 5
Depreciation 46 77 60 74 87 104 154 167 115 80 17 8
Profit before tax 107 63 85 145 165 188 216 -13 -437 -779 -99 -118
Tax % 17% 2% 6% 14% 11% 15% 17% 15% -3% -0% -2% -1%
89 62 80 125 146 160 178 -11 -450 -782 -100 -120
EPS in Rs 6.49 4.74 5.71 9.78 10.74 10.85 11.99 -0.84 -30.56 -52.88 -6.78 -8.09
Dividend Payout % 15% 21% 17% 10% 9% 15% 8% 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: -22%
5 Years: -50%
3 Years: -56%
TTM: -65%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: 23%
TTM: 70%
Stock Price CAGR
10 Years: -5%
5 Years: -30%
3 Years: -32%
1 Year: 28%
Return on Equity
10 Years: -6%
5 Years: -31%
3 Years: -106%
Last Year: -55%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity Capital 12 12 12 12 13 15 15 15 15 15 15 15
Reserves 408 458 512 619 898 1,314 1,504 1,561 1,110 166 94 -24
196 207 209 336 237 323 474 553 514 59 46 37
220 185 189 246 221 189 339 336 187 984 69 60
Total Liabilities 837 862 922 1,214 1,369 1,840 2,331 2,465 1,826 1,223 224 88
368 384 359 543 554 589 1,091 1,234 934 101 73 30
CWIP 3 2 17 3 21 42 41 1 0 3 11 0
Investments 50 50 6 21 10 59 10 18 7 0 0 0
415 426 541 647 785 1,150 1,188 1,213 885 1,119 140 58
Total Assets 837 862 922 1,214 1,369 1,840 2,331 2,465 1,826 1,223 224 88

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
117 100 74 151 56 121 104 211 135 30 20 9
-70 -91 -14 -292 -130 -179 -474 -233 -57 15 -3 -7
-31 -7 -11 111 56 302 100 21 -84 -55 -36 -12
Net Cash Flow 16 2 49 -30 -18 243 -270 -2 -6 -10 -18 -10

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 99 100 120 107 118 108 94 116 205 45 58 39
Inventory Days 12
Days Payable 260
Cash Conversion Cycle 99 100 120 107 118 108 94 116 205 45 58 -209
Working Capital Days 71 83 121 107 136 143 142 137 289 45 20 -135
ROCE % 20% 11% 13% 16% 17% 15% 13% 1% -9% -6% -14%

Shareholding Pattern

Numbers in percentages

Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
53.41% 53.41% 53.41% 53.41% 53.41% 53.41% 53.41% 53.41% 53.41% 53.41% 53.41% 53.41%
1.61% 1.55% 1.38% 0.84% 0.75% 0.41% 0.13% 0.13% 0.13% 0.00% 0.00% 0.02%
0.27% 0.28% 0.28% 0.28% 0.04% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
44.71% 44.76% 44.93% 45.47% 45.80% 46.19% 46.44% 46.45% 46.46% 46.57% 46.59% 46.56%
No. of Shareholders 86,09989,98686,24790,96890,36388,46986,92483,95082,04581,18379,33681,938

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Concalls